“It is possible that doses of that could be available for clinical trial in two to three months, but there is a lot of uncertainty,” a spokesman added, saying it would depend on animal trials as to whether it could be considered “a promising candidate research vaccine” for Bundibugyo.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Explore More

Analysis reveals an additional mechanism behind statin therapy’s heart-related benefits in people with HIV

Investigators who previously found that a daily statin pill helps prevent heart attacks and strokes in people with HIV have now discovered a potential mechanism that may help to stabilize

Brain neurotransmitter receptor antagonist found to prevent opioid addiction in mice

New research led by UCLA Health has found a drug that treats insomnia works to prevent the addictive effects of the morphine opioids in mice while still providing effective pain

Medicaid in the Crosshairs, Maybe

The Host The future of the Medicaid health insurance program for those with low incomes is in doubt, as Congress works on a budget plan calling for major cuts while